Viktor Sapezhnikov

Viktor Sapezhnikov is a Corporate Partner at Wachtell Lipton. He focuses on mergers and acquisitions, corporate governance and general corporate and securities matters. Viktor’s practice has included a wide range of matters, including domestic and cross-border acquisitions, divestitures, business combinations, private equity transactions, joint ventures and spin-offs. Viktor also advises companies and their boards on takeover defense, shareholder activism and proxy contests.

Viktor received a B.A. summa cum laude from Marist College in 2005. He also completed a general course program at the London School of Economics in 2004. Viktor received his J.D. from Columbia Law School in 2009, where he was a James Kent Scholar and finance editor of the Columbia Business Law Review.

Viktor was named a Rising Star by Law360 for 2020 and is a member of the New York State Bar Association and the New York City Bar.

Technology, Media and Telecommunications

Broadcom in its

• $150 billion proposal to acquire Qualcomm
• $18.9 billion all-cash acquisition of CA Technologies
• $10.7 billion all-cash acquisition of the enterprise security business of Symantec
• $950 million sale of Veracode to Thoma Bravo
• divestiture of its Cyber Security Services business to Accenture
• global preferred services partnership with HCL Technologies
• Publicis Groupe S.A. in its $4.4 billion acquisition of Alliance Data Systems’ Epsilon business
• Charter Communications in its
• $78.7 billion merger with Time Warner Cable
• $10.4 billion acquisition of Bright House Networks
• wireless cooperation agreement with Comcast
• GCP Applied Technologies in its $1.05 billion sale of its Darex Packaging Technologies business to Henkel
• Expedia in its $3.9 billion acquisition of HomeAway
• TEGNA in its
• $250 million sale of CareerBuilder to Apollo Global Management and the Ontario Teachers’ Pension Plan Board
• spin-off of Cars.com
• Motorola Solutions in its
• extension of its strategic partnership with Silver Lake, including a $1 billion investment from Silver Lake and settlement of existing $800 million of convertible notes held by Silver Lake
• $965 million secondary offering of Motorola Solutions shares of common stock by entities affiliated with Silver Lake
• initial entry into a strategic partnership with Silver Lake, which included a $1 billion investment by Silver Lake, and self-tender offer to purchase up to $2 billion of common stock
• $3.45 billion sale of its Enterprise business to Zebra Technologies
• BMC Software in its $6.9 billion sale to an investor group including Bain Capital, Golden Gate Capital, GIC Special Investment and Insight Venture Partners
• Gannett in the separation of its publishing business and its broadcasting and digital business through a spin-off of the publishing business
• The Special Committee of the Board of Directors of Activision Blizzard in an $8.2 billion purchase of shares of Activision from Vivendi, its controlling stockholder, by Activision and ASAC II L.P., an investment vehicle formed by CEO Bobby Kotick and Co-Chairman Brian Kelly
• Corning in its $1.9 billion acquisition of the remaining 50% interest in Samsung Corning Precision Materials from Samsung Display and other minority shareholders and the structuring of Samsung Display’s $2.3 billion investment in and strategic collaboration with Corning

Real Estate

• Taubman in a $9.8 billion merger and joint venture with Simon Property Group
• Prologis in its $12.6 billion acquisition of Liberty Property Trust
• Forest City Realty Trust in its $11.4 billion sale to Brookfield
• Public Storage in connection with the €2 billion initial listing of Shurgard Europe
• Annaly Capital Management in its
• $1.5 billion acquisition of Hatteras Financial
• $900 million acquisition on MTGE Investment
• Quality Care Properties in its $3.9 billion acquisition by Welltower, including its related agreement with ProMedica Health System to acquire HCR ManorCare through a bankruptcy reorganization
• Regency Centers in its $15.6 billion merger with Equity One
• Healthcare, Pharmaceuticals and Biotechnology
• Varian Medical Systems in
• its $16.4 billion sale to Siemens Healthineers
• the spin-off of its Imaging Components business
• Frutarom in its
• $7.1 billion sale to International Flavors & Fragrances
• $290 million acquisition of Enzymotec
• AbbVie in its $7.5 billion modified Dutch auction tender offer to repurchase its common stock
• Medtronic in its $6.1 billion sale of a portion of its Patient Monitoring & Recovery Division to Cardinal Health
• Hologic in its $1.65 billion acquisition of Cynosure
• Valeant Pharmaceuticals in its $1.3 billion sale of its CeraVe, Ambi and Acne Free brands and related assets to L’Oréal USA
• Abbott Laboratories in its $25 billion acquisition of St. Jude Medical
• Covidien in its
• $49.9 billion acquisition by Medtronic
• $2.5 billion spinoff of Mallinckrodt, its pharmaceuticals business
• Mallinckrodt in its
• $5.6 billion acquisition of Questcor Pharmaceuticals
• $2.3 billion acquisition of Ikaria
• $1.4 billion acquisition of Cadence Pharmaceuticals
• $1.325 billion acquisition of Therakos

Energy

• Spectra Energy in its $28 billion merger of equals with Enbridge
• Greenskies Renewable Energy in its sale to Clean Focus
• Ameren Corporation in its sale of Ameren Energy Resources Company to Illinois Power Holdings, a subsidiary of Dynegy
• Doosan Corporation in its acquisition of the assets of ClearEdge Power in a Section 363 bankruptcy sale
• Retail, Manufacturing and Other
• PetSmart in a $8.7 billion leveraged buyout by a private equity consortium led by BC Partners
• First Quality Enterprises in its
• sale of its nonwovens operations in the United States and China to R2G Rohan Czech.
• acquisition of Fempro
• FMC Corporation in its $1.8 billion acquisition of Cheminova

• Marist College, B.A. 2005, summa cum laude
• London School of Economics and Political Science, General Course 2004
• Columbia Law School, J.D. 2009, James Kent Scholar (Finance Editor, Columbia Business Law Review)